RLY-2608
( DrugBank: RLY-2608 / KEGG DRUG: - )
3 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 138 | Nerve cell migration disorder | 1 |
| 278 | Huge lymphatic malformation with cervicofacial lesion | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 281 | Klippel-Trenaunay-Weber syndrome | 1 |
138. Nerve cell migration disorder
Clinical trials : 2 / Drugs : 4 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathways : 106
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
278. Huge lymphatic malformation with cervicofacial lesion
Clinical trials : 47 / Drugs : 48 - (DrugBank : 15) / Drug target genes : 8 - Drug target pathways : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
281. Klippel-Trenaunay-Weber syndrome
Clinical trials : 4 / Drugs : 4 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathways : 52
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
